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Background: The COVID-19 pandemic indirectly impacts HIV
epidemiology in Central/West Africa. We estimated the potential impact
of COVID–19-related disruptions to HIV prevention/treatment services
and sexual partnerships on HIV incidence and HIV-related deaths
among key populations including female sex workers (FSW), their
clients, men who have sex with men, and overall.
Setting: Yaoundé (Cameroon) and Cotonou (Benin).
Methods: We used mathematical models of HIV calibrated to city
population–specific and risk population–specific demographic/behavioral/
epidemic data. We estimated the relative change in 1-year HIV incidence
and HIV-related deaths for various disruption scenarios of HIV
prevention/treatment services and decreased casual/commercial partner-
ships, compared with a scenario without COVID-19.
Results: A 50% reduction in condom use in all partnerships over 6
months would increase 1-year HIV incidence by 39%, 42%, 31%, and
23% among men who have sex with men, FSW, clients, and overall in
Yaoundé, respectively, and 69%, 49%, and 23% among FSW, clients,
and overall, respectively, in Cotonou. Combining a 6-month interruption
of ART initiation and 50% reduction in HIV prevention/treatment use
would increase HIV incidence by 50% and HIV-related deaths by 20%.
This increase in HIV infections would be halved by a simultaneous 50%
reduction in casual and commercial partnerships.
Conclusions: Reductions in condom use after COVID-19 would
increase infections among key populations disproportionately,
particularly FSW in Cotonou, who need uninterrupted condom
provision. Disruptions in HIV prevention/treatment services have the
biggest impacts on HIV infections and deaths overall, only partially
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mitigated by equal reductions in casual/commercial sexual partner-
ships. Maintaining ART provision must be prioritized to minimize
short-term excess HIV-related deaths.
Key Words: HIV, COVID-19, key populations, Cameroon, Benin,
mathematical model
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INTRODUCTION
Disruptions associated with the COVID-19 pandemic and
response1 (hereafter simplified to “COVID-19”) may inadver-
tently impact the HIV epidemic in at least 2 ways.2–7 First, an
increasing number of countries and organizations reported
disruptions in traditional and safe in-person HIV prevention
and treatment services due to COVID-19.8–21 Second, COVID-
19 has been associated with disruptions in casual22,23 and
commercial24,25 sexual partnerships due to increased physical
distancing and closure of sex work venues.
Key populations (KPs), such as female sex workers
(FSW),26 their clients, and men who have sex with men
(MSM)27 may be particularly vulnerable to these disrup-
tions.28,29 Community outreach and KP HIV prevention pro-
grams in sub-Saharan Africa have increased online services, but
with decreased reported uptake.17,18,30–32 KPs experience higher
levels of stigma,25,33 are more affected by the economic impact
of COVID-19,29 and may have limited access to online health
platforms, potentially reducing use of health services, as well as
condoms and antiretroviral therapy (ART). For example, a
recent global survey among MSM (n = 10,654) suggested that
nearly half of MSM living with HIV (45%, N = 1254) were
unable to refill their HIV medicine prescription remotely.34
However, limited demand for sex work from clients and the
closure of venues where some commercial and same-sex sexual
partnerships are formed could create fewer opportunities for HIV
transmission.35,36
Early modeling studies assessed the potential overall
population-level impact of different hypothetical HIV
prevention/treatment disruption scenarios37–39 across sub-
Saharan Africa. These studies suggested that a complete
interruption of all ART services for 6 months among 50% of
treated people living with HIV (PLHIV) may increase annual
new HIV infections by 1.6 fold,38 but did investigate the
heterogeneity in impact by the risk group, which is particularly
important for HIV epidemics in Central and West Africa.
Empirical programmatic or behavioral data measuring the effects
of COVID-19 on intervention uptake or sexual behaviors are
only starting to emerge, but translating these disruption estimates
from such studies into population-level impact on HIV can only
be done conducted using mathematical models.
Yaoundé and Cotonou are the largest cities of Cameroon
and Benin, respectively, in Central and West Africa, with 3%
and 1% HIV prevalence among people aged 15–49 years. As in
most African settings, KPs have been shown to be dispropor-
tionately affected by HIV and are an important part in HIV
transmission and control.40–42 Compared with the overall
populations, FSW HIV prevalence in Yaoundé and Cotonou is
approximately 5 and 9 times higher,43,44 respectively, and
around 10 times higher among MSM in Yaoundé.43,45
The first COVID-19 cases in Cameroon and Benin
were recorded on the 6th and 16th of March 2020,
respectively, but the countries have since experienced
different COVID-19 epidemics. In January 2021,
Cameroon had recorded 455 COVID-19 deaths and 28,000
cases, whereas Benin had reported very few deaths (n = 46)
and cases (n = 3400).1 On March 18th 2020, Cameroon
implemented the first set of COVID-19 mitigation measures
with the closure of international borders and schools46 and
the closure of bars and restaurants in the evenings, which
impacted commercial sex.47 Additional measures were
implemented in April, including the creation of COVID-19
health centers in all regional capitals. The country started
easing lockdown measures on May 1st, when bars/
restaurants were allowed to stay open in the evenings,48
whereas schools and universities reopened in early June.
Similar measures to those in Cameroon were implemented in
Benin, including the closure of bars and nightclubs on
March 23rd, but only within specific geographic hotspots,
such as Cotonou.49 Although bar gatherings were still
officially limited to 50 people in both countries in January
2021, it is not systematically enforced by Cameroon
authorities.50,51 The COVID-19 pandemic and responses to
it have substantially impacted countries’ economies,52
which could subsequently affect commercial sex. KPs have
been more severely affected by both countries’ response and
economic difficulties, and several mass arrests of KPs have
been reported in Cameroon.53–55 Despite Cameroon having
implemented universal free HIV testing and treatment in
January 2020,56 a recent Ministry of Health report suggests a
10% reduction in new HIV diagnoses over January/June
2020 compared with January/June 2019.57 A survey con-
ducted among FSW (n = 407) in Greater Cotonou in
September and October 2020 assessed the impact of
COVID-19-related disruption on sex work activity in the
city.58 The large majority of respondents (88%) reported that
clients had become “rare” in hotspots. More than a third
(36%) of FSW reported a reduction in the price of sex work
since the arrival of the COVID-19 pandemic in the country,
and two-thirds of FSW (68%) reported a decrease in
spending power due to COVID-19.
To inform countries on the likely impact of COVID-19
on HIV using currently available data,59 we conducted a
comparative mathematical modeling study60 and estimated
how various data driven and hypothetical scenarios of 3-
month, 6-month, and 12-month disruptions in ART services
and condom provision, and reductions in sexual activity,
may influence the number of new HIV infections and HIV-
related deaths over 1 and 5 years in Yaoundé and Cotonou,
among KPs and the overall populations. We compared the
independent and combined population-level impact of the
different disruptions, overall, and by risk populations. Our
analysis generates new results allowing to (1) determine and
identify which type and levels of COVID-19 disruptions has
the largest population-level impact on HIV, and therefore
need to be prevented in priority impacts, and (2) to rapidly
interpret and further our understanding of the likely impacts
on HIV as more data emerge on different level of COVID-
19 disruptions.
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METHODS
Yaoundé and Cotonou HIV Models
For these analyses, we used 2 existing models
specifically developed and calibrated to the population
and HIV epidemiology of each setting.61,62 The models are
very similar, and the slight differences reflect the specific
epidemiology and data available in each city. Table 1
shows the main characteristics of the HIV epidemics and
levels of interventions, including among KPs. After
successful programs aiming to reduce FSW HIV acquisi-
tion and transmission, condoms are more readily used by
FSW than the rest of the population, with an estimated 81%
and 91% of commercial sex acts involving condoms in
2020 in Yaoundé and Cotonou, respectively.42,43,63–65
Similarly, condom use among MSM in Yaoundé is twice
as frequent then among non-KPs.43,66 In early 2020, ;43%
of all PLHIV were estimated to be virally suppressed in
TABLE 1. HIV Epidemic Profile of the 2 Cities: Population Structure, Sexual Behaviors, HIV Prevalence, and Intervention Levels in
Yaoundé (Cameroon) and Cotonou (Benin)
Yaoundé Cotonou
Population structure
% FSW among all females 1.5% (0.5–3.0)43,120,121 0.30%* (0.27–0.38)72,91,122–125
% Clients among all males 16.0% (7.9–19.7)66,76,92,93,126 21.3% (12.6–25.9)64,90,122–125
% MSM among all males 1.8% (1.0–2.2)43,121 NA
Sexual behaviors
FSW:
No. of commercial sex acts (per year) 493 (304–932)43,76,78,121,127 648 (194–1546)44,65,80,82,84,88,90
No. of noncommercial sex acts (per year) 368 (231–303)43 27 (15–44)44,65,80,82–84,88
Clients:
No. of sex acts (per year) 233 (168–380)73,128 121 (89–162)44,82,84,90
MSM:
No. of sex acts with male partners (per year) 172 (109–212)43 NA
No. of sex acts with female partners (per year) 140 (120–157)43 NA
Lower-risk populations:
No. of sex acts (per year) 100 (71–120)128 38 (29–47)81,86
Fraction of sex acts which are with casual partners. 2093 20%†
HIV prevalence
FSW 13.9% (11.9–16.4)43 8.5% (7.1–11.2)81,84,85,129
Clients 3.5% (2.5–4.6)73 1.5% (0.9–2.2)65
MSM 31.1% (26.9–34.8)43,130,131 NA
Lower-risk females 4.9% (3.9–5.9)66 1.0% (0.8–1.5)86
Lower-risk males 1.8% (1.3–2.4)66 0.6% (0.3–0.9)86
% Condom use at last sex
FSW during paid sex 81.2% (73.5–94.0)43 91.4% (86.0–98.2)44,81
FSW during unpaid sex 53.7% (47.5–65.0)43 39.9% (21.7–59.9)44,81,83
MSM 65.7% (57.7–77.5)43 NA
Lower-risk populations 29.1% (20.0–39.5)66,95 20.7% (16.2–25.5)81
ART and viral suppression coverage in PLHIV
FSW: % on ART 87.3% (81.3–91.9) 72.0% (63.1–80.6)
% Virally suppressed 69.9% (63.8–74.3)43 57.1% (49.7–66.2)68,69,99
Clients: % on ART 46.7% (40.5–52.5) 58.8% (42.0–73.4)
% Virally suppressed 37.4% (32.1–42.5)73 35.8% (20.2–55.8)68,69,99,101
MSM: % on ART 49.2% (43.4–54.8) NA
% Virally suppressed 39.6% (34.4–44.9)43
Lower-risk females: % on ART 54.5% (50.4–59.9) 74.9% (64.7–83.2)
% Virally suppressed 43.8% (40.1–48.3)67,132 46.8% (31.4–65.4)68,69,99,101
Lower-risk males: % on ART 48.6% (42.7–53.4) 68.3 (50.4–80.6)
% Virally suppressed 39.2% (34.2–43.0)67,132 42.0% (23.3–63.0)68,69,99,101
Median and 95% UI (2.5th and 97.5th percentiles) of posterior distributions in January 2020 are shown.
The Cotonou model also represented women receiving less than half of their income from commercial sex [“part-time FSW,” 0.27% (0.23–0.33) of all women]. The combined
posterior size of both groups was 0.70% (0.56–0.87).
*FSW were defined as women reporting most of their income as originating from commercial sex.
†Casual partnerships were not explicitly modeled in Cotonou, as no data were available. A fraction of 20% of noncommercial sex acts of all risk groups were assumed to be with
casual partners, to match estimates from Yaoundé DHS.
NA, not available as not modeled in Cotonou.
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both cities67,68 with higher suppression among FSW (70%
and 57% in Yaoundé and Cotonou, respectively43,69).
Both models were deterministic compartmental mod-
els of HIV transmission which stratified the population by
gender, sexual risk group, HIV infection stage, and ART
status. They were parameterized to reflect city-specific
empirical estimates of demographic (eg, growing population
size) and sexual behavioral characteristics, as well as the
HIV prevalence and HIV intervention levels (eg, condom
use and male circumcision66,70) among relevant risk groups
over time. Newly infected individuals progressed through an
acute infection stage, then chronic stages, associated with
HIV mortality (see Figures 1b, 8, Supplemental Digital
Content, http://links.lww.com/QAI/B630). PLHIV could
initiate and drop out from ART and a fraction of treated
PLHIV were virally suppressed and experienced reduced
HIV-related mortality and infectiousness.
The 2 models represented FSW (women reporting
commercial sex as their major source of income), move-
ment in and out of sex work [ending engagement in
commercial sex and/or migration (Cotonou model only,
information not available for FSW in Yaoundé)],71 and
their clients. Each risk group could form heterosexual
noncommercial (main and casual) partnerships. In the
Yaoundé model, FSW could form sexual partnerships with
all male groups,43,61 but commercial sex with clients only,
whereas they could only form partnerships with clients in
the Cotonou model, because of lower reported numbers of
noncommercial sex acts by FSW in Cotonou, and the high
proportion of seasonal migrants in this group (see Figures
1a, 7, Supplemental Digital Content, http://links.lww.com/
QAI/B630). The Yaoundé model also included younger
(aged 15–24 years) and older (aged 25–49 years) MSM
because of their very high HIV prevalence.43 The Cotonou
model did not represent MSM but represented part-time sex
workers72 (ie, “bar girls”), who were excluded from the
outcome calculations for the FSW group.
The per-capita rate at which HIV-uninfected people
acquire HIV in each model depended on the frequency of
commercial and noncommercial partnerships, number of sex
acts per partnership with and without condoms, sexual mixing
between groups, as well as HIV prevalence, viral suppression
and disease stage among partners, and efficacies of different
interventions (see equations in supplement, Supplemental
Digital Content, http://links.lww.com/QAI/B630).
Parameterization and Calibration
Multiple data sources informed the parameters and
fitted outcomes for the 2 models (Tables 1–3 and Figures 2–6
for Yaoundé; Tables 4–9 and Figures 9–18 for Cotonou,
Supplemental Digital Content, http://links.lww.com/QAI/
B630). Data included recent KP surveys in Yaoundé43,63,73–79
and Cotonou,44,72,80–91 as well as general population
surveys.66–68,75,76,81,85–87,92–101 Both models were fitted
within a Bayesian framework, accounting for uncertainties
in parameters (eg, number of partners) and fitted data (eg,
HIV prevalence).
Model Analysis: Base-Case Scenario
We defined a “base–case” scenario for each model,
reflecting the expected course of the HIV epidemic in the
absence of COVID–19-related disruptions over 2020–2024.
The base–case scenarios project that the UNAIDS
90-90-90 targets would not have been achieved by 2024.
The fraction of PLHIV virally suppressed is expected to
increase from 43% to 50% over 2020–2024 in Yaoundé, and
from 44% to 45% over 2020–2024 in Cotonou (Table 1). The
proportion of individuals on ART who are virally suppressed
(80% and 70% in Yaoundé and Cotonou, respectively), and
condom use within the different partnership types, was
conservatively assumed to remain fixed at their last reported
levels throughout the simulations (Figures 4 and 16, Supple-
mental Digital Content, http://links.lww.com/QAI/B630).
Pre-exposure prophylaxis is not available in either country
outside of KP-specific demonstration projects,102 and so is
not modeled.
Model Analyses: Disruption Scenarios
We defined several disruption scenarios informed by
the first empirical studies describing worldwide disruptions in
HIV prevention/treatment and sexual partnerships due to
COVID-19.16,20,22,23,29,35,57,58,103–105
These temporary disruptions were simulated indepen-
dently and in different combinations when applied to the
entire population or restricted to specific subgroups. The
Table 10, Supplemental Digital Content, http://links.lww.
com/QAI/B630 details the scenarios as well as their justifi-
cation and plausibility with more details.
We considered potential disruptions in levels of ART
initiation and adherence due to reduced outreach and access to
ART clinics, as well as ART supply issues. Early data from
Cameroon suggest a 32% decrease in ART initiations during
January–June 2020 compared with January–June 2019106
(despite Cameroon having implemented free ART testing and
treatment in January 2020), as well as a 10% decrease in the
proportion of PLHIV on ART who are virally suppressed in
June 2020 compared with December 2019 (80% vs 88%).57
Several African countries (n = 7) reported being at medium or
high risk of ART stockout in a World Health Organisation
(WHO) survey conducted between April and June 2020.9
However, this survey also showed that African national health
systems prescribed ART for 3–6 months, which could increase
the resilience of ART access channels. We considered reduc-
tions in overall condom use resulting from reduced outreach and
potential disruption in condom provision.29,104,105 Larger reduc-
tions were anticipated to occur among KP because of their
higher dependency on HIV programs, as well as the larger
impact of the COVID-19 response on their income.25,59 In
Cotonou, 21% of FSW have reported a decrease in the
distribution of free condoms due to the COVID-19 response.58
In the 2016 IBBS in Cameroon, FSW reported being offered
more money for sex without a condom an average of 5.2 times
in the past month, and accepted more money for sex without a
condom an average of 2.3 times.43 There are no data on the price
of sex by condom use in Yaoundé, whereas the reported median
price received by FSW in Cotonou for a condomless sex acts
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was 4000 franc de la Communauté financière africaine, vs 2250
franc de la Communauté financière africaine for sex act with a
condom,107 suggesting that the loss of income due to economic
circumstances could lead to a decrease in condom use by FSW.
Finally, we considered reductions in number of casual and
commercial partners because of increased physical distancing.
Although no data are currently available on changes in partner
numbers in Africa, it has been reported by many studies from
high-income countries, and suggested by African press arti-
cles.22,23,103,104 Significant reductions in the number of com-
mercial partners are suggested by a recent survey in Cotonou
where 88% of surveyed FSW reported that clients were “rare” in
hotspots.58
We defined as single disruptions reductions in (1) ART
initiations, (2) proportion of PLHIV on ART who are virally
suppressed, (3) condom use, (4) number of casual partnerships
among all risk groups, and (5) commercial partnerships between
FSW and their clients (details in Table 2). We explored 2 specific
condom use scenarios: reductions within commercial (3a) and
noncommercial partnerships (3b) separately. In addition, 3
setting-specific scenarios (reflecting specificities in HIV epidemics
and models) were defined as follows: reductions in (6) HIV
testing in Cotonou, (7) number of noncommercial partnerships
between MSM in Yaoundé, and (8) condom use to the same
levels as among the lower-risk population among MSM, FSW,
and clients in Yaoundé (corresponding to.50% decrease in their
condom use), which reflects higher HIV prevention efforts and
intervention use among KP compared with lower-risk groups.
Two Cotonou-specific scenarios explored the closure of bars and
cessation of sex work by bar girls assuming either that (9a) there
is no concomitant increase in commercial sex of clients with full-
time FSW to compensate for the contacts “lost with bar girls”, or
(9b) the client demand for sex work with bar girls is maintained
and instead met by full-time FSW.
The second set of scenarios combined the 5 main single
disruptions additively (eg, 1, 1 + 2, ., 1 + 2 + 3 + 4 + 5) to
assess the impact of simultaneous disruptions. We explored
reductions of 10/25/50% in each scenario. In scenario 1, we
also examined no ART initiations. The “most realistic”
scenario, exploring reductions of 10% in levels of HIV viral
suppression, large reductions in ART initiations, as well as
decreases in condom use and risky sex, best reflected early
empirical estimates from Cameroon’s National AIDS Control
Committee and a recent survey among FSW in Cotonou.57,58
Finally, the third set explored disruptions to ART
initiations and viral suppression (1 + 2) and condom use (3)
among KPs alone, to estimate what proportion of the overall
impact was attributable to these groups.
TABLE 2. Overall Impact of Risk group–specific Disruptions: Relative Increase in New HIV Infections and HIV-Related Deaths
overall Over 1 year Due to: A) Cessation of New ART Initiations and 50% Reduction in the Proportion of Virally Suppressed Among
Those on ART in all and Specific Risk Groups and B) 50% Reduction in all Condom Use in all and Specific Partnerships (Impact on
HIV Incidence Only)
% HIV-Related Deaths % New HIV Infections
Yaoundé Cotonou Yaoundé Cotonou
A)
Affected risk group
All 15.7% (11.2–19.0) 22.4% (11.8–46.9) 21.4% (18.3–26.0) 19.0% (10.5–32.7)
FSW and clients 1.7% (0.9–2.7) 3.3% (1.5–7.9) 5.5% (3.0–8.5) 10.3% (5.3–17.6)
Non-FSW and non-clients 13.7% (10.0–17.5) 19.5% (9.4–39.2) 16.2% (12.5–20.1) 9.0% (4.9–15.9)
FSW 0.7% (0.3–1.6) 0.3% (0.2–0.5) 2.3% (0.8–4.4) 3.8% (1.9–6.3)
Clients 1.0% (0.4–1.6) 3.1% (1.3–7.6) 3.2% (1.5–5.0) 6.0% (2.7–12.5)
MSM 1.1% (0.4–1.6) NA 5.5% (2.1–8.5) NA
FSW, clients, and MSM 2.9% (1.7–3.9) NA 11.1% (6.5–14.6) NA
Non-FSW, non-clients, and non-MSM 12.6% (8.8–16.6) NA 11.1% (6.7–15.3) NA
B)
Affected partnerships
All 22.6% (14.6–31.1) 23.1% (12.3–48.6)
FSW and clients with all partners 8.5% (4.8–13.7) 21.4% (11.4–46.8)
Between FSW and clients 4.5% (2.0–9.3) 18.5% (8.9–42.0)
Non-FSW and non-clients with all partners 17.3% (11.2–25.2) 4.2% (2.6–6.3)
Between non-FSW and nonclients 14.2% (7.7–21.1) 1.5% (0.8–2.6)
MSM with all partners 10.6% (4.7–17.9) NA
FSW with all partners 5.9% (2.6–10.8) 18.5% (8.9–42.0)
Clients with all partners 7.0% (4.0–12.2) 21.4% (11.4–46.8)
MSM, FSW, and clients with all partners 18.9% (13.1–28.4) NA
Between MSM, FSW, and clients 10.9% (6.3–17.0) NA
Non-MSM, non-FSW, and non-clients with all
partners
10.3% (6.4–16.0) NA
Between non-MSM, non-FSW, and non-clients 3.5% (1.4–6.9) NA
NA, not available as not modeled in Cotonou.
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The indirect impacts of COVID-19 on HIV outcomes
were calculated as the relative change (expressed as a
percentage of the base-case) in new HIV infections and
HIV-related deaths over 1 and 5 years from the start of
disruptions [assumed to last 6 months (primary analysis) and
3 and 12 months (sensitivity analyses)] starting in January
2020 in Cotonou, and April 2020 in Yaoundé). These impacts
were evaluated for the overall population and within each risk
group. We report the median and 95% uncertainty interval of
the predicted disruption impact.
RESULTS
Single HIV Prevention/Treatment and Sexual
Behavior Disruptions—Overall Impact
Our model-predicted impacts of COVID-19 on HIV
outcomes were of similar magnitude in Cotonou and
Yaoundé. We found that COVID–19-related changes in
condom use may impact HIV incidence slightly more than
disruptions to ART and viral suppression but have a
negligible impact on HIV-related mortality compared with
any of the ART disruptions (Fig. 1).
Our worst-case single scenario (temporary 50% reduc-
tion in viral suppression over 6 months) increased new overall
HIV infections by 18% (95% uncertainty interval 16–22) and
14% (7–27) and increased HIV-related deaths by 13% (9–16)
and 21% (11–44) over 1 year in Yaoundé and Cotonou,
respectively, compared with the base–case (Figs. 1A, B).
When assessed over 5 years, the impact of the 6-month
disruptions was reduced to 6% (5–7) and 4% (2–7) relative
increases in HIV infections, and 4% (3–5) and 4.0% (2–9)
increases in HIV-related deaths in Yaoundé and Cotonou,
respectively (see Figure 19, Supplemental Digital Content,
http://links.lww.com/QAI/B630). Temporarily ceasing ART
initiations over 6 months, suspending HIV testing, and 10%
reduction in viral load suppression are expected to have small
impacts on HIV incidence and mortality (,5%).
A temporary 50% reduction in all condom use over 6
months was predicted to increase new HIV infections by 23%
(15–31) and 23% (12–49) over 1 year in Yaoundé and Cotonou,
respectively [8% (5–10) and 8% (4–18) over 5 years, see Figure
19, Supplemental Digital Content, http://links.lww.com/QAI/
B630]. This will also result in a small increase in HIV-related
deaths even over 5 years (#2%). In Cotonou, the impact of a 6-
month 50% decrease in condom use during commercial sex on
overall new HIV infections [19% (9–42)] was substantially
larger than during noncommercial sex (4% (3–6)), whereas it
was the opposite for Yaoundé [4% (2–9) during commercial sex
vs 18% (12–26) during noncommercial sex, Figure 1].
The positive impact of 50% reductions in the number of
casual or commercial partners on reducing HIV infections
was smaller [Yaoundé: 7% (4–11), Cotonou: 5% (4–6) over 1
year] than the negative impact for the corresponding 50%
reductions in condom use.
Finally, our model results suggest that closing bars in
Cotonou is likely to have a negligible impact on HIV if clients
demand for sex work with bar girls was not compensated by an
increased demand for full-time FSW. If instead client demand
for sex with bar girls was met by full-time FSW over 6 months,
FIGURE 1. First set of scenarios: relative change in the cumulative number of HIV infections (A) and HIV-related deaths (B) over 1
year under individual scenarios assuming 6-month disruptions, compared with base–case in Yaoundé (gray) and Cotonou (black).
Dots represent median estimates across model predictions, whereas lines represent 95% UI (2.5th and 97.5th percentile of the
estimates). UI, uncertainty interval.
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annual new HIV infections could increase by 1% (-1-3) and 5%
(0%–15%) overall and among FSW, respectively. This modest
impact was due to the small number of partnerships of part-time
FSW with clients compared with full-time FSW.
Single HIV Prevention/Treatment and Sexual
Behavior Disruptions—Impact Among
Different Risk Groups
We estimated that KPs would be more severely impacted
by the effects of COVID-19 disruptions compared with the rest
of the population. For example, the impact of a 6-month 50%
reduction in all condom use on new HIV infections would be
1.7-fold, 1.9-fold, and 1.4-fold larger over 1 year among MSM,
FSW, and their clients than among the overall population in
Yaoundé, respectively (Fig. 2). Differences were even more
pronounced for Cotonou where it would be 3.0-fold and 2.1-fold
larger among FSW and their clients than overall, respectively,
reflecting higher consistency in condom use during commercial
sex in the Cotonou model compared with the Yaoundé model.
Estimated impacts on HIV-related mortality and infections over
5 years are shown in Figures 20–22, Supplemental Digital
Content, http://links.lww.com/QAI/B630.
Combined Disruptions—Impact Among
Specific Risk Groups and Overall
Our models predicted qualitatively similar impacts of
combined disruptions on HIV outcomes across the 2 cities
(Fig. 3). Although the negative impact of combined ART and
condom provision disruptions could be substantial, the effect
on HIV infections, but not mortality, could be partially offset
(and largely among FSW and their clients) by a reduction in
numbers of partners.
The most realistic scenario, best reflecting early data from
the cities (assuming a 3-month universal cessation of new ART
initiations, and 10% reduction in viral suppression coverage,
condom use, and number of casual and commercial partner-
ships) led to an overall increase in annual new HIV infections of
less than 10% in both cities (Figure 23, Supplemental Digital
Content, http://links.lww.com/QAI/B630).
In our worst-case combined scenario [6-month con-
comitant universal cessation of new ART initiations, 50%
reduction in viral suppression coverage and in condom use
(scenarios 1 + 2 + 3)] overall 51% (39–67) and 51% (29–90)
more new HIV infections over 1 year were predicted in
Yaoundé and Cotonou (Figs. 3A, C), respectively. This
impact is double what was achieved for any of the 5 single
disruptions alone, and 1.4-fold and 1.9-fold higher among
FSW and clients combined compared with the overall in
Yaoundé and Cotonou, respectively (Figs. 3B–D).
However, if these disruptions coincide with a 50%
reduction in casual and commercial partnerships (scenarios 1
+ 2 + 3 + 4 + 5), the impact on new HIV infections is
attenuated to 29% (19–42, corresponding to 990 (710–1420)
excess infections) and 19% (8–36, corresponding to 60
(30–130) excess infections) in Yaoundé and Cotonou over
1 year, with little heterogeneity in impact across risk groups,
apart from among MSM in Yaoundé for which it was 1.2-fold
higher than overall.
FIGURE 2. Impact of disruptions among risk groups: relative change in the cumulative number of new HIV infections in Yaoundé
(squares) and Cotonou (triangles) over 1 year under individual scenarios assuming 6-months disruptions, calculated overall (green dots and
lines), among MSM (pink dots and lines), FSW (red dots and lines), and their clients (blue dots and lines). Dots represent median point
estimates across model predictions, whereas lines represent 95% UI (2.5th and 97.5th percentile of the estimates).
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The estimated increases in HIV-related mortality in
combined scenarios (1 + 2 + 3 + 4 + 5) were around 20% in
both cities [corresponding to 390 (264–484) and 150
(80–270) excess HIV-related deaths over 1 year], among
FSW and their clients combined and overall (Figs. 3E–H).
However, the specific estimates among FSW alone were 2.1-
fold and 1.6-fold higher than overall in Yaoundé and
Cotonou, respectively (not shown). The estimated impacts
FIGURE 3. Impact of combined dis-
ruption scenarios: relative change in the
cumulative number of new HIV infec-
tions among (A) overall population and
(B) FSW and their clients in Yaoundé,
(E) overall population and (F) FSW and
their clients in Cotonou, and HIV-
related deaths over 1 year among (C)
overall population and (D) FSW and
their clients in Yaoundé, (G) overall
population and (H) FSW and their cli-
ents in Cotonou under additive com-
bined scenarios assuming no ART
initiations and 10/25/50% reductions.
Boxplots represent median, inter-
quartile range and 95% UI across
model predictions.
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of combined disruptions over 5 years and impacts among
MSM, FSW, and clients combined were more modest (see
supplement, Supplemental Digital Content, http://links.lww.
com/QAI/B630).
ART and Condom Use Disruptions Among
Specific Risk Groups—Overall Impact
In both settings, KPs contributed disproportionately to
the overall impact of disruptions on new HIV infections. We
estimated that a 50% reduction in viral load suppression
among MSM, FSW, and their clients increased new HIV
infections by over half the amount incurred by 50% reduction
in all groups. (Table 2). Similarly, the overall impact of
disruptions in condom use on new HIV infections in Cotonou
could be mainly due to disruptions among FSW and their
clients (21% vs 23% overall) and mainly due to disruptions
among KP in Yaoundé (19% vs 23% overall). However, most
of the impact on HIV-related mortality was due to reductions
in lower-risk populations as they comprise most PLHIV on
ART in both cities (Table 2).
Sensitivity Analysis: Impact of Shorter/Longer
Combined Disruptions
Both models estimated that the overall impact of
universal disruptions to prevention and treatment interven-
tions on new HIV infections and HIV-related deaths would
vary relatively proportionately with their duration (Figure 24,
Supplemental Digital Content, http://links.lww.com/QAI/
B630). The exception was disruptions related to HIV testing
in Cotonou and ART initiation in Yaoundé, for which longer
disruptions were associated with proportionately lower rela-
tive impact on HIV outcomes.
DISCUSSION
The results presented here suggest that HIV prevention
and treatment disruptions due to COVID-19 are likely to
disproportionately impact KP and that severe disruptions
(50% reduction in HIV prevention and treatment levels over 6
months) may increase overall HIV infections and HIV-related
mortality by 1.5-fold in Yaoundé and Cotonou. Although
additional HIV infections due to COVID-19 would impact the
quality of life of populations, they would not necessarily
translate into additional future HIV-related deaths if HIV
treatment coverage quickly increases above pre-COVID-19
levels, after a resumption of full services. Most HIV-related
deaths would be due to declines in the proportion of PLHIV
that were virally suppressed or initiated on ART.
Our most realistic scenario assuming modest reductions
(10%) in levels of viral suppression, condom use, and
nonsteady partnerships, as well as a substantial decrease in
the number of new ART initiations over a period of 3 months
was consistent with early data collected in both countries
during the first wave of the COVID-19 pandemic. The impact
of these disruptions on HIV outcomes in both cities was
relatively modest, with less than a 10% increase in annual
new HIV infections. Early information for sub-Saharan
Africa, such as the WHO Global AIDS Monitoring data9
suggest that ART delivery and countries responses, for
example through multimonth dispensing of ART, has reduced
ART disruptions during the first COVID-19 pandemic wave
in Africa, indicating that our scenarios reflecting severe
disruptions should be considered as relatively unlikely. That
said, both models suggest that even small disruptions to ART
could lead to substantial increases in number of HIV-related
deaths. More data could become available and show more
severe disruptions; in that case, our scenarios would be useful
to determine whether these disruptions are likely to have a
large impact on HIV.
Our analysis highlights the disproportionate impact of
COVID-19 disruptions on KPs. These populations are already
more vulnerable to HIV, often living in precarious financial
situations,28 and our findings suggest that high levels of HIV
prevention and treatment must be maintained to minimize the
overall impact of disruptions on new infections. Sex work and
sex between men are legal in Benin, but still criminalized in
Cameroon where KPs are subjected to increased arbitrary
arrests during the COVID-19 era,108 which means that they
hide even more, making it difficult to reach them, especially
in a context where street outreach activities are reduced for
legitimate safety concerns.17,18 In both models, a modest
reduction in condom use, especially during commercial sex,55
translated into a substantial increase in absolute numbers of
condomless sex acts. For example, a 50% decrease in condom
use during commercial sex resulted in a 6.8-fold increase in
number of condomless acts for FSW in Cotonou, reflecting
the achievements and importance of programs leading to
extremely frequent condom use during commercial sex.
Our estimates of the impact of 6-month universal
interruptions of ART initiation on new HIV infections and
HIV-related deaths (;4% and 2% increase) were similar to
published impact estimates across sub-Saharan Africa.38,109
For example, a 5-model comparison exercise by Jewell et al38
suggested ART interruptions could increase new HIV infec-
tions and HIV-related deaths by 0%–4% and 0%–6%,
respectively. Our estimated impact from a 50% decrease in
viral load suppression for 6 months among treated PLHIV
was also similar to estimates from the 5-model exercise.38
However, our models predicted a larger impact from a 50%
reduction in condom use on new HIV infections (23%
increase in both cities) compared with the 5-model study
[range: 3% (0–13) to 19% (7–30) across models38] due to
higher levels of baseline condom use among PLHIV in our
study settings.
Our models predicted that the negative impact of HIV-
related service disruptions could only be partially offset by
changes in sexual partnerships. Temporary reductions in
sexual partnerships had less impact than temporary reductions
in condom use due to high levels of condom use among KP
before the COVID-19 outbreak in these cities. We found that
changes in sexual partnerships, and especially commercial
sex in Cotonou, could partly offset the impact of service
disruptions on new HIV infections, but would not compensate
for the impact of an equal reduction in viral suppression alone
(Fig. 3). Thus, taken together with the disproportionate
impact of HIV-related service disruptions on KPs, our
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findings underscore the need for maintaining successful
condom promotion and use among KPs through safe access
of services. Early program data on intervention levels among
KPs in West and Central Africa suggest increasing and
decreasing trends of the number of FSW reached by programs
in Cote d’Ivoire and Togo, respectively, over January-July
2020, a decrease in the number of MSM reached by
interventions in Togo over 2020, and substantial decreases
in the number of condoms distributed to MSM in Togo over
2020.110
Although the overall impact of the different disruptions
was qualitatively similar across the 2 cities, our analysis
highlighted some differences reflecting variation in underly-
ing epidemic dynamics and intervention coverage. Commer-
cial sex partnerships and condom use are more important
determinants of HIV transmission in Cotonou compared with
Yaoundé, because the HIV epidemic is more concentrated
among FSW and their clients in Cotonou (despite the
relatively smaller size of the FSW and part-time sex worker
populations in Cotonou). The level of overall viral suppres-
sion is similar across the 2 cities; however, 70% of FSW
living in HIV in Yaoundé are virally suppressed, compared
with less than 60% in recent surveys among FSW in Cotonou,
ART adherence being substantially affected by high turnover
and migration in this population.111 Nevertheless, the simi-
larities suggest that our results may be broadly applicable to
places where KPs such as FSW are already disproportionately
affected by HIV.
Strengths of our analysis include comprehensive
reviews of city-specific and risk group–specific data over
time to characterize the dynamics of the modeled populations
and the HIV epidemic in 2020. To the best of our knowledge,
this is the first analysis of the impact of COVID-19
disruptions on HIV outcomes among KPs, allowing us to
better identify how to minimize disruption impacts. Limita-
tions include simulating disruption scenarios derived from
early published studies and reports of HIV prevention/
treatment services and of sexual behaviors affected by
COVID-19, most of which were conducted outside Africa.
The use of hypothetical magnitudes of disruptions was due to
the absence of quantitative data from Cotonou and scarcity of
data for Yaoundé106 (which only describes reductions in ART
initiations) at the time of this analysis. Thus, an important
next phase of the study includes empiric data characterizing
service disruptions and changes in the practice of sex work,
sex between men, and condomless sex. Combining hypothet-
ical magnitudes of disruptions with mathematical models
allowed the understanding of which specific magnitudes of
disruptions would induce “tolerable” increases in new HIV
infections or deaths (eg, ,5% over 1 year), and conversely,
which disruption levels must be prevented. Our approach will
allow the assessment of the potential impact of COVID–19-
related disruptions on HIV epidemics in Central and West
Africa when more data become available. However, our study
highlights the fact that “tolerable” increases at the overall
level might obscure much more significant impacts among
KPs. Our models only accounted for the secondary and
indirect effects of the COVID-19 pandemic and did not
account for direct and specific COVID-19 mortality among
PLHIV.112–116 We did not explicitly model other potential
consequences of the economic fallout from COVID-19 on
commercial sex, such as an increase in riskier (eg, condom-
less) commercial sex,117,118 which could amplify the negative
impact of the COVID-19 outbreak on the local
HIV epidemics.
To conclude, the COVID-19 pandemic might have a
substantive negative impact on new HIV infections and
deaths, especially among key populations, undermining
recent efforts in controlling the HIV epidemic across Central
and West Africa.119 Innovative approaches addressing and
maintaining ART services for all PLHIV, and in particular,
the HIV prevention and treatment needs of KPs—including
their safe access—would constitute an efficient way
to minimize negative impacts on new HIV infections in
subsequent waves of the COVID-19 pandemic.
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